Vaccine therapy

Global $7.61 Billion Cancer Vaccines (Preventive, Therapeutic) Markets, 2015-2019, 2023F, 2025F, 2030F - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 29, 2021
Pharmaceutical, Health, Oncology, Vaccination, Medical specialties, Clinical medicine, Medicine, Cancer vaccines, Vaccines, Virology, Vaccine, Cancer vaccine, Vaccine therapy, Tumor antigen vaccine

Cancer Vaccines Global Market Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cancer vaccines global market market.

Key Points: 
  • Cancer Vaccines Global Market Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cancer vaccines global market market.
  • The cancer vaccines market consists of sales of vaccines used for the treatment of cancers and related services by entities (organizations, sole traders and partnerships) that produce vaccines for cancer treatment.
  • The cancer vaccines market covered in this report is segmented by type into preventive cancer vaccines; therapeutic cancer vaccines.
  • It is also segmented by technology into dendritic cells (DC) cancer vaccines; recombinant cancer vaccines; antigen/adjuvant cancer vaccines; whole cell cancer vaccines; viral vector & DNA cancer vaccines, by cancer type into prostate; cervical; colorectal; throat; others and by end-user into cancer treatment centers; research institutes.

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

Retrieved on: 
Friday, May 28, 2021
Health sciences, Life sciences, Medical specialties, Vaccination, Vaccine therapy, Therapy, Vaccine, Dendritic cell, Biopharmaceutical

tella is a Japanese company contributing to the advancement of cancer therapy through the research and development of cancer vaccines.

Key Points: 
  • tella is a Japanese company contributing to the advancement of cancer therapy through the research and development of cancer vaccines.
  • tellas dendritic cell vaccine therapy aims to increase the dendritic cell population and strengthen the attacking system against cancers.
  • In 2019, tellas dendritic cell vaccine therapy has been provided to approximately 12,200 patients in 28 medical institutions around Japan.
  • Beroni Group is an Australia-based biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases.

Global Opportunity Analysis and Industry Forecast in the Cancer Vaccines Market to 2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 4, 2021
Pharmaceutical, Health, Oncology, Medical specialties, Vaccination, Branches of biology, Medicine, Vaccines, Virology, Cancer vaccines, Vaccine, Gene delivery, Viral vector, Cancer vaccine, Vaccine therapy

The "Cancer Vaccines Market by Technology Cancer Vaccines, Type, Indication, End User - Global Opportunity Analysis and Industry Forecast, 2019 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cancer Vaccines Market by Technology Cancer Vaccines, Type, Indication, End User - Global Opportunity Analysis and Industry Forecast, 2019 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Increasing administration of prophylactic cancer vaccines and rising investments for the development of new cancer vaccines are expected to fuel the cancer vaccines market growth.
  • Moreover, factors such as emphasis on early diagnosis of cancer, introduction & approval of cancer vaccines and technological developments are expected to boost the demand for cancer vaccines market growth.
  • On the basis of technology, the market is segregated into dendritic cells cancer vaccines, recombinant cancer vaccine, antigen cancer vaccine and viral vector & DNA cancer vaccines.

Europe Cancer Vaccines Markets, 2019-2020 & 2027 - Dendritic Cells Cancer Vaccines Segment to Grow at Fastest Rate

Retrieved on: 
Thursday, December 10, 2020
Vaccination, Medical specialties, Medicine, Clinical medicine, Vaccines, Vaccine, Virology, Cancer vaccines, Cancer vaccine, Viral vector, Vaccine therapy, Therapeutic vaccines

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines.

Key Points: 
  • Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines.
  • The in recombinant cancer vaccines segment held the largest share of the market in 2019.
  • Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.
  • Market growth in Europe Cancer Vaccines is mainly due to factors such as increasing prevalence of cancer and rising government initiatives to prevent cancer.

Europe Cancer Vaccines Market Forecast to 2027 with COVID-19 Impact Insights - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 3, 2020
Health, Biotechnology, Vaccination, Medical specialties, Medicine, Clinical medicine, Vaccine, Cancer vaccine, Viral vector, Vaccine therapy, Therapeutic vaccines

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines.

Key Points: 
  • Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines.
  • The in recombinant cancer vaccines segment held the largest share of the market in 2019.
  • Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.
  • Market growth in Europe Cancer Vaccines is mainly due to factors such as increasing prevalence of cancer and rising government initiatives to prevent cancer.

Analysis on Impact of COVID-19- Global Therapeutic Vaccines Market 2020-2024 | Evolving Opportunities with Aimmune Therapeutics Inc. and Immune Response BioPharma Inc.| Technavio

Retrieved on: 
Tuesday, November 3, 2020
Infectious diseases, Health, Medical Supplies, Medical specialties, Vaccination, Virology, Clinical medicine, Medicine, Vaccine, Therapeutic vaccines, Vaccines, Remune, Autogenous vaccines, Vaccine therapy

In addition, the increase in R&D activities related to novel therapeutic vaccines is anticipated to boost the growth of the therapeutic vaccines market.

Key Points: 
  • In addition, the increase in R&D activities related to novel therapeutic vaccines is anticipated to boost the growth of the therapeutic vaccines market.
  • The increase in the prevalence of infectious diseases and chronic diseases has driven the demand for therapeutic vaccines.
  • The market has witnessed the development of various therapeutic vaccines by top vendors in the market.
  • Headquartered in the US, Immune Response BioPharma Inc. offers various therapeutic vaccines, such as RAVAX, NeuroVax, Zorcell, and RemuneX.

Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, November 2, 2020
Pharmaceutical, Health, Oncology, Medical specialties, Vaccination, Branches of biology, Clinical medicine, Vaccine, Virology, Vaccines, Virotherapy, Viral vector, Vaccine therapy

The "Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The report highlights trends prevailing in the global cancer vaccines market, and the drivers and restraints pertaining to the market growth.
  • Based on technology, the cancer vaccines market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines.
  • The global cancer vaccines market growth is mainly attributed to factors such as increasing incidence of cancer worldwide, and rising number of initiatives taken by healthcare research organizations and key cancer vaccines companies.

Therapeutic Vaccines Industry Analysis and Forecast 2015-2025 (COVID-19 Adjusted)

Retrieved on: 
Thursday, May 7, 2020
Vaccination, Medical specialties, Medicine, Vaccine, Health, Cancer vaccine, Vaccine therapy, HIV vaccine

The Global Therapeutic Vaccines Market is expected to grow at a double digit CAGR during the forecast period, on account of increasing awareness in the population about prevalence of fatal and chronic diseases.

Key Points: 
  • The Global Therapeutic Vaccines Market is expected to grow at a double digit CAGR during the forecast period, on account of increasing awareness in the population about prevalence of fatal and chronic diseases.
  • Since vaccines are prepared for a special type of disease, it can be said that the market is the demand-based market.
  • The type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others.
  • The companies operating in the Global Therapeutic Vaccines Market are adoption inorganic and organic growth strategies to increase their share in the market.

Impact of COVID-19 on Global Therapeutic Vaccines Market, 2020 and Beyond - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 6, 2020
Health, Pharmaceutical, Vaccination, Medical specialties, Medicine, Vaccine, Health, Cancer vaccine, Vaccine therapy, HIV vaccine

The Global Therapeutic Vaccines Market is expected to grow at a double digit CAGR during the forecast period, on account of increasing awareness in the population about prevalence of fatal and chronic diseases.

Key Points: 
  • The Global Therapeutic Vaccines Market is expected to grow at a double digit CAGR during the forecast period, on account of increasing awareness in the population about prevalence of fatal and chronic diseases.
  • Since vaccines are prepared for a special type of disease, it can be said that the market is the demand-based market.
  • The type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others.
  • The companies operating in the Global Therapeutic Vaccines Market are adoption inorganic and organic growth strategies to increase their share in the market.

Visiongain Report Offers Transformative Insights on the $5.5bn mRNA Vaccines and Therapeutics Market

Retrieved on: 
Wednesday, July 10, 2019
Branches of biology, Life sciences, Biology, Vaccination, Vaccine, Virology, Messenger RNA, Vaccine therapy

LONDON, July 10, 2019 /PRNewswire/ -- Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy, Cell Therapy

Key Points: 
  • LONDON, July 10, 2019 /PRNewswire/ -- Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy, Cell Therapy
    The mRNA Vaccines and Therapeutics Market is estimated at $3.43 billion in 2018.
  • The Standardized Therapeutic Cancer mRNA Vaccines segment held a share of 35.47% in 2018 and is projected to grow with a CAGR of 9.77% in next ten years.
  • The 184-page report provides clear detailed insight into the mRNA Vaccines and Therapeutics Market.
  • To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/mrna-vaccines-and-therapeutics-market-...
    Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by type:
    Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by Mechanism of Action: